# To studyJUV-161 Administered to Healthy Volunteers Undergoing Unilateral Lower Limb Immobilization (ULLI)

> **NCT07397468** · PHASE1,PHASE2 · RECRUITING · sponsor: **Juvena Therapeutics** · enrollment: 36 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** JUV-161
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07397468
- **Lead sponsor:** Juvena Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-28
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07397468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07397468, "To studyJUV-161 Administered to Healthy Volunteers Undergoing Unilateral Lower Limb Immobilization (ULLI)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07397468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*